CPT® Code 90700

Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use

The CPT® Code 90700 refers to the Diphtheria, Tetanus Toxoids, and Acellular Pertussis vaccine (DTaP), specifically designed for intramuscular administration in individuals who are younger than 7 years of age. This vaccine plays a crucial role in immunization by providing long-lasting immunity against three serious bacterial infections: diphtheria, tetanus, and pertussis (whooping cough). The term 'toxoid' refers to a toxin that has been rendered non-toxic but still retains the ability to stimulate an immune response. By introducing these toxoids into the body, the vaccine prompts the immune system to produce antibodies that can neutralize the actual toxins produced by the bacteria if encountered in the future. The DTaP vaccine is particularly significant as it not only protects against these diseases but also does so with a reduced risk of side effects, thanks to the acellular pertussis component. This component is a more purified version of the pertussis vaccine, which minimizes adverse reactions while still effectively stimulating the immune system. The administration of this vaccine is vital for young children, as they are at a higher risk for severe complications from these infections. Code 90700 specifically captures the supply of this immunization product, emphasizing its role in safeguarding the health of pediatric patients by ensuring they receive the necessary protection against these preventable diseases.